BIOMOTIV
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines. BioMotiv is the mission-aligned development company of The Harrington Project for Discovery and Development. The Harrington Project, unveiled in February by University Hospitals (UH), is a first-of-its-kind $250 million initiative that promises to revolutionize how new breakthrough drugs are advanced to market. By aligning the upstream efforts of the recently created UH Case Medical Center’s Harrington Discovery Institute with the downstream development efforts of BioMotiv, The Harrington Project seeks to accelerate the therapeutic innovation process for the benefit of patients globally. The company was founded in 2012 and is headquartered in Cleveland, Ohio.
BIOMOTIV
Social Links:
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
2012-01-01
Status:
Active
Contact:
216-455-3200
Email Addresses:
[email protected]
Total Funding:
166.83 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Domain Not Resolving Global Site Tag
Similar Organizations
Huntington Memorial Research Institute
Huntington Medical Research Institutes specializes in biotech and life sciences.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Investors List
Takeda Ventures
Takeda Ventures investment in Venture Round - BioMotiv
Nationwide Mutual Capital
Nationwide Mutual Capital investment in Venture Round - BioMotiv
Harrington Family
Harrington Family investment in Venture Round - BioMotiv
University Hospitals
University Hospitals investment in Venture Round - BioMotiv
University Hospitals
University Hospitals investment in Venture Round - BioMotiv
Harrington Family
Harrington Family investment in Venture Round - BioMotiv
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-17 | Amphista Therapeutics | BioMotiv investment in Series B - Amphista Therapeutics | 53 M USD |
| 2021-01-05 | Aro Biotherapeutics | BioMotiv investment in Series A - Aro Biotherapeutics | 88 M USD |
| 2020-04-07 | Amphista Therapeutics | BioMotiv investment in Series A - Amphista Therapeutics | 7.5 M USD |
| 2018-12-11 | Aro Biotherapeutics | BioMotiv investment in Venture Round - Aro Biotherapeutics | 13 M USD |
| 2017-01-27 | Allinaire Therapeutics | BioMotiv investment in Seed Round - Allinaire Therapeutics | 1.57 M USD |
| 2014-04-28 | Orca Pharmaceuticals | BioMotiv investment in Venture Round - Orca Pharmaceuticals | 1.3 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-02-05 | BioMotiv announces appointment of Satish Jindal as CEO |
More informations about "BioMotiv"
BioMotiv | Harrington Discovery Institute at University Hospitals
BioMotiv aligns drug development expertise, capital, and pharmaceutical partners to accelerate discoveries into medicines. BioMotiv provides: Pharmaceutical expertise — The company's …See details»
BioMotiv - Crunchbase Investor Profile & Investments
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines. BioMotiv is the mission-aligned development company of The Harrington Project for Discovery and …See details»
BioMotiv - LinkedIn
BioMotiv is the mission-driven accelerator associated with The Harrington Project for Discovery & Development, a $340 million US and UK initiative for advancing medicine centered at …See details»
BioMotiv Company Profile | Management and Employees List
BioMotiv Profile and History. BioMotiv is a mission-driven accelerator associated with The Harrington Project for Discovery & Development, a $340 million initiative focused on …See details»
Advancing Pulmonary Arterial Hypertensions (PAH) Therapeutic
Aug 15, 2023 BioMotiv’s support continued as the focus of Allinaire’s research shifted from COPD to pulmonary arterial hypertension (PAH). Allinaire is now targeting PAH as the first …See details»
BioMotiv, LLC | Ohio Life Sciences
BioMotiv, LLC. Return to Directory. Categories Research & Development. Description. 2000 Auburn Drive, Suite 200 Beachwood, OH 44122-4328 . BioMotiv, LLC is the development …See details»
BioMotiv and University of Pittsburgh Announce Formation of …
Sep 1, 2017 Formed by BioMotiv and University of Pittsburgh CLEVELAND AND PITTSBURGH — SEPTEMBER 21, 2017 — BioMotiv, a drug development accelerator associated with The …See details»
BioMotiv - VentureRadar
Dec 31, 2016 Accelerates breakthrough discoveries into medicines by operating as a mission-driven pharmaceutical accelerator with a singular focus. " BioMotiv is the mission-driven, for …See details»
BioMotiv | VentureRadar
BioMotiv is the mission-driven, for-profit therapeutic accelerator affiliated with The Harrington Project for Discovery and Development, a $250 million initiative announced by University …See details»
BioMotiv: Contact Details and Business Profile - RocketReach
BioMotiv is the mission-driven accelerator associated with The Harrington Project for Discovery & Development, a $340 million US and UK initiative for advancing medicine centered at …See details»
BioMotiv - Contacts, Employees, Board Members, Advisors & Alumni
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines.See details»
BioMotiv - Investments, Portfolio & Company Exits - Crunchbase
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines. How many investments has this organization made over time? ShowSee details»
BioMotiv - Company Database - Wall Street Oasis
BioMotiv is the mission-driven accelerator associated with The Harrington Project for Discovery & Development, a $340 million US and UK initiative for advancing medicine centered at …See details»
BioMotiv Overview | SignalHire Company Profile
BioMotiv is a private company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Biotechnology areas. ... Organization Website: biomotiv.com …See details»
BioMotiv - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
BioMotiv - Biotech Careers
BioMotiv is a mission-driven pharmaceutical accelerator with a singular focus: Accelerating Breakthrough Discoveries into Medicines Business Areas: Incubators and AcceleratorsSee details»
Baiju Shah, CEO of BioMotiv, talks about new financing models
Biotech accelerator CEO Baiju Shah talks about BioMotiv, the organization he leads and the new financing models that are changing how early stage companies a...See details»
BioMotiv - Crunchbase
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines.See details»
BioMotiv of Biology Topics | Question AI
BioMotiv Industry Biotechnology Founded Cleveland, Ohio, 2012 Key people Baiju Shah , CEO Subsidiaries Allinaire Therapeutics Dual Therapeutics Kodosil Bio Koutif Therapeutics Nynex …See details»